Associated Papers
Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry.
Berro R et al.
Plos Pathogens, 2009
CCR5-Mediated human immunodeficiency virus entry depends on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domains.
Genoud S et al.
Journal of Virology, 1999
Select a paper to view details